Patent details

EP3977985 Title: COMPOSITIONS COMPRISING PGI2-RECEPTOR AGONISTS AND PROCESSES FOR THE PREPARATION THEREOF

Basic Information

Publication number:
EP3977985
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP211921929
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
COMPOSITIONS COMPRISING PGI2-RECEPTOR AGONISTS AND PROCESSES FOR THE PREPARATION THEREOF
French Title of Invention:
COMPOSITIONS COMPRENANT DES AGONISTES DU RÉCEPTEUR PGI2 ET PROCÉDÉS DE PRÉPARATION ASSOCIÉS
German Title of Invention:
ZUSAMMENSETZUNGEN MIT PGI2-REZEPTORAGONISTEN UND VERFAHREN ZU DEREN HERSTELLUNG
SPC Number:

Dates

Filing date:
01/03/2018
Grant date:
06/09/2023
EP Publication Date:
06/04/2022
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
06/09/2023
EP B1 Publication Date:
06/09/2023
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
01/03/2024
Expiration date:
01/03/2038
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
20/10/2023
 
 

Name:
Arena Pharmaceuticals, Inc.
Address:
66 Hudson Boulevard East, New York, NY 10001-2192, United States (US)

History of Owners

From:
30/08/2023
To:
20/10/2023

Name:
Arena Pharmaceuticals, Inc.
Address:
235 East 42nd Street, New York, NY 10017, United States (US)

Inventor

1

Name:
SELVEY, Lee Alani
Address:
United States (US)

2

Name:
SHAO, Zezhi Jesse
Address:
United States (US)

3

Name:
LI, Ching-Yuan
Address:
United States (US)

4

Name:
FLORIDA, Raizza Berania
Address:
United States (US)

Priority

1

Priority Number:
201762465675 P
Priority Date:
01/03/2017
Priority Country:
United States (US)

2

Priority Number:
201762468832 P
Priority Date:
08/03/2017
Priority Country:
United States (US)

3

Priority Number:
201762526039 P
Priority Date:
28/06/2017
Priority Country:
United States (US)

4

Priority Number:
201762530515 P
Priority Date:
10/07/2017
Priority Country:
United States (US)

Classification

IPC classification:
A61K 9/20; A61K 31/27; A61K 9/16; A61K 9/28; A61K 9/48;

Publication

European Patent Bulletin

1

Issue number:
202336
Publication date:
06/09/2023
Description:
Grant (B1)

2

Issue number:
202347
Publication date:
22/11/2023
Description:
Change of owner's name or address

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages